PAR 4.84% 29.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-121

  1. 1,101 Posts.
    lightbulb Created with Sketch. 211
    I think we need to wait for the MPS results & confirmation of the dose by the FDA that's when there would be partnerships IMO
    The problem is that's very soon & now the deals are by June 2024 I thought they said Q1 2024 before but I might be wrong.
    If they don't happen soon I can't see why things suddenly align in June
    Last edited by Weazel: 01/02/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.015(4.84%)
Mkt cap ! $103.1M
Open High Low Value Volume
30.5¢ 30.5¢ 29.5¢ $86.19K 286.7K

Buyers (Bids)

No. Vol. Price($)
4 70151 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 18600 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.